Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 In this email you will find a link to our special anniversary issue of the HCV Advocate. It is hard to believe that the Hepatitis C Support Project / HCV Advocate has been in existence for over 10 years now! Thank you for your continued support and encouragement. On behalf of the staff of the Hepatitis C Support Project / HCV Advocate Web site we all would like to wish you a happy, healthy, and prosperous 2008. Cheers, Alan ***January 2008 HCV Advocate Newsletter Download English printable version Download Spanish printable version -------- Happy Anniversary Lucinda Porter AASLD 2007 - Part 2: More Drugs in DevelopmentAlan Franciscus, Editor-in-ChiefDisability & Benefits: Public Benefits & Residency RequirementsJacques Chambers, CLUCan Mosquitoes Spread HCV?Alan Franciscus, Editor-in-ChiefTop Eleven News Stories of 2007Alan Franciscus, Editor-in-ChiefInterferon Maintenance Therapy and Liver Disease ProgressionLiz Highleyman ***Updated Factsheets • Extrahepatic Manifestations of HCV • HCV Education and Support ***HEPATITIS JOURNAL REVIEW:A Bi-Monthly Publication of the Hepatitis Support ProjectDecember 25, 2007Volume 4, Issue 23 Liz Highleyman To download pdf version click here In This Issue:Hepatitis C• Eltrombopag Boosts Platelet Count• G-CSF for Neutropenia• Genotype 1b Linked to HCC, Post-transplant Recurrence• Hepatotoxicity in HIV/HCV Coinfected Patients• Antiretroviral Therapy Improves Cirrhosis in Coinfected Patients *** HCV ADVOCATE WEEKLY NEWS REVIEW: A Review of HCV, HBV and HIV/HCV Coinfection Related News and HighlightsWeek Ending: December 22nd , 2007 To download pdf version click here This Issue: San Francisco hospital to help sick in Vietnam Update on Chronic Hepatitis B Milk thistle, liver health The public's right to know Medivir and Tibotec collaborate for hepatitis C treatment GlobeImmune Announces Initiation of Phase 2 Clinical Trial of GI-5005 in Patients With Chronic Hepatitis C Standard Hepatitis B Treatment Bested by Newcomer Gov't rejects uniform compensation for all hepatitis C sufferers Valeant Pharmaceuticals Sells Hep-C Drug Infergen® to Three Rivers Pharmaceuticals®, LLC for $91 Million Possible New Way to Detect, Monitor Liver Disease Without Painful Liver Biopsy Conatus Pharmaceuticals Initiates a Phase 2 Clinical Trial for the Treatment of Hepatitis Data About Zetia Risks Was Not Fully Revealed Infection in blood, donors unaware Pair indicted on fraud charges in medical-device probe Romark raises $18 million Thanks! Alan FranciscusExecutive Director, Hepatitis C Support ProjectEditor-in-Chief, HCV Advocate Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.